Utilization and Cost of Outpatient Rehabilitation Services for Pediatric Patients Treated for Acute Lymphoblastic Leukemia Using a Commercial Claims Database.

Only commercially insured patients were included, so results may not apply to publicly insured patients or other cancer types. The analysis used one commercial insurance network and claims data, so missing or unsubmitted services could distort use and cost. PT and OT were combined because modifier codes were often absent, so the paper cannot separate PT from OT. Race and ethnicity were partly imputed and 29% were missing, so differences by race or ethnicity should be read cautiously. The study did not capture inpatient rehabilitation, orthotics, other durable medical equipment, reasons for service, or whether services were for cancer or non-cancer problems. It reports service use and cost, not patient outcomes, so it cannot show whether rehabilitation helped or whether delays harmed patients. The cohort was limited to patients who survived and had 36 months continuous coverage, so early deaths or coverage gaps are not represented.

The supplied text tags the article as supported by NIH and non-U.S. government research, but it does not state author conflicts of interest or whether a funder designed or wrote the study.

Do not read rising PT/OT use as proof that rehabilitation improves pediatric ALL outcomes. This paper reports insurance claims for service use and cost, not patient function, toxicity, or benefit.